Institutional investors purchased a net $3.4 million shares of MNKD during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 27.81% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREYWOLF CAPITAL MANAGEMENT LP Bought 3.5 Million shares of Mannkind Corp
THE VANGUARD GROUP, INC. Bought 1.7 Million shares of Mannkind Corp
MORGAN STANLEY & CO. LLC Bought 1.6 Million shares of Mannkind Corp